Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · Real-Time Price · USD

0.2700

-0.0051 (-1.85%)

At close: Apr 16, 2026, 4:00 PM EDT

0.2772

+0.0072 (2.67%)

After-hours: Apr 16, 2026, 7:38 PM EDT

Sangamo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	39.55	57.8	176.23	111.3	110.7
Revenue Growth (YoY)	-31.57%	-67.20%	58.34%	0.54%	-6.34%
Gross Profit	39.55	57.8	176.23	111.3	110.7
Selling, General & Admin	34.89	44.73	61.17	62.68	63.22
Research & Development	112.67	111.52	234.06	249.9	230.82
Other Operating Expenses	13.24	5.52	155.01	-	-
Total Operating Expenses	160.79	161.77	450.24	312.58	294.04
Operating Income	-121.24	-103.97	-274.01	-201.28	-183.34
Interest Income	1.3	1.51	11.1	9.43	5.35
Other Non-Operating Income (Expense)	-3.56	4.35	-	-	-
Total Non-Operating Income (Expense)	-2.26	5.86	11.1	9.43	5.35
Pretax Income	-123.5	-98.11	-262.9	-191.85	-177.99
Provision for Income Taxes	-0.57	-0.17	-5.07	0.43	0.31
Net Income	-122.93	-97.94	-257.83	-192.28	-178.29
Minority Interest in Earnings	-	-	-	-	-0.01
Net Income to Common	-122.93	-97.94	-257.83	-192.28	-178.29
Shares Outstanding (Basic)	280	202	174	154	145
Shares Outstanding (Diluted)	280	202	174	154	145
Shares Change (YoY)	38.92%	15.62%	13.02%	6.76%	7.53%
EPS (Basic)	-0.44	-0.49	-1.48	-1.25	-1.23
EPS (Diluted)	-0.44	-0.49	-1.48	-1.25	-1.23
Shares Outstanding	350.69	212.84	178.13	166.79	145.92
Free Cash Flow	-97.31	-67.41	-246	-243.8	-256.53
Free Cash Flow Per Share	-0.35	-0.33	-1.41	-1.58	-1.77
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-306.53%	-179.88%	-155.48%	-180.85%	-165.62%
Profit Margin	-310.81%	-169.45%	-146.30%	-172.76%	-161.06%
FCF Margin	-246.03%	-116.62%	-139.59%	-219.05%	-231.73%
EBITDA	-117.6	-99.72	-266.88	-192.83	-175.14
EBITDA Margin	-297.33%	-172.52%	-151.44%	-173.25%	-158.21%
EBIT	-121.24	-103.97	-274.01	-201.28	-183.34
EBIT Margin	-306.53%	-179.88%	-155.48%	-180.85%	-165.62%
Effective Tax Rate	0.46%	0.17%	1.93%	-0.22%	-0.17%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q